Please provide your email address to receive an email when new articles are posted on . SGLT2 inhibition may improve CV outcomes in patients with diabetes undergoing cancer therapy. The ...

Please provide your email address to receive an email when new articles are posted on . Women who developed HF following cardiotoxic breast cancer treatment had fewer comorbidities and better overall ...

Three abstracts presented at this year’s annual meeting of the American Society of Clinical Oncology focused on cardiotoxic effects of cancer treatment and how cardiac disease remains a barrier to ...

Harmful side effects from a common chemotherapy drug could be the result of a single mutation, according to a study published in Cell Stem Cell. The cardiotoxic effects of the chemotherapy drug ...

Future Cardiol. 2012;8(4):647-670. Although redox-induced damage is likely involved in anthracycline-induced cardiotoxicity, some evidence suggests that it is not the only mechanism at play. Several ...

MEMPHIS, TN — When researchers screened close to 2000 adults who had survived childhood cancer but had been exposed to cardiotoxic cancer-related therapy, they found "considerable," almost always ...

Impact of an Epstein-Barr Virus Serology-Based Screening Program on Nasopharyngeal Carcinoma Mortality: A Cluster-Randomized Controlled Trial We evaluated 2,808 echocardiograms in 829 breast cancer ...

SGLT2 inhibitors may worsen heart failure outcomes from chemotherapy, highlighting the need for further long-term studies on cardiotoxicity, explains Rakendu Rajendran, MBBS. At the ASPC 2025 Congress ...

Moderate drinkers who like to indulge in a glass of wine or beer with dinner have long taken comfort in the fact that most doctors believe this habit could do no harm or could even be good for your ...

Doxorubicin (Doxo) is a widely used chemotherapeutic drug for cancer, though it can have toxic effects on the heart. A recent animal study investigated whether the cardioregulatory protein ...